세계의 심장 안전 서비스 시장 - 규모, 점유율, 동향분석 보고서 : 서비스별, 유형별, 최종용도별, 지역별, 부문 예측(2025-2030년)

Cardiac Safety Services Market Growth & Trends:

The global cardiac safety services market size is anticipated to reach USD 1,924.3 million by 2030 and is projected to grow at a CAGR of 12.1% from 2025 to 2030, according to a report by Grand View Research, Inc. This growth is driven by the alarming prevalence of cardiovascular diseases (CVDs) and significant advancements in medical technology. As per the CDC, in U.S., one person dies due to any cardiovascular disease every 33 seconds, underscoring the critical need for effective cardiac monitoring and intervention. In 2022, heart disease caused 702,880 deaths, representing one in every five deaths and highlighting the vast market potential for cardiac safety services.

Moreover, approximately 805,000 people in the U.S. experience a heart attack each year, with 605,000 being first-time incidents and 200,000 involving individuals who have previously suffered a heart attack. Expanding clinical trials, particularly those focused on cardiovascular diseases or involving therapies with potential cardiovascular impacts, drives the demand for cardiac safety services. As pharmaceutical and biopharmaceutical companies invest in developing new cardiovascular drugs and devices, there is an increased need for specialized cardiac safety assessments to ensure that these products do not adversely affect heart health. This growth in clinical trials, combined with the complexity of modern trials, necessitates robust and reliable cardiac safety services to support drug development and regulatory compliance.

Pharmaceutical companies, medical device manufacturers, and academic institutions continually invest in R&D to drive innovation and growth in the cardiac safety services market. Research initiatives often require sophisticated cardiac safety monitoring to support the development of new therapies and technologies. This investment fosters the development of new cardiac safety solutions and supports continuously improving existing services.

Cardiac Safety Services Market Report Highlights:

• Based on service, the ECG/Holter monitors segment led the market with the largest revenue share of 41.0% in 2024. Electrocardiogram (ECG) and Holter monitors are crucial tools for continuous cardiac monitoring, enabling real-time detection of arrhythmias, ischemic episodes, and other cardiovascular conditions
• Based on type, the integrated segment led the market with the largest revenue share of 63.0% in 2024. This prominence is primarily driven by the increasing demand for comprehensive, multi-functional cardiac monitoring solutions that offer enhanced accuracy, efficiency, and patient convenience
• Based on end use, the pharma & biopharma segment led the market with the largest revenue share of 44.0% in 2024

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Service
  • 1.2.2. Type
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Service Outlook
  • 2.2.2. Type
  • 2.2.3. End Use
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Cardiac Safety Services Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of cardiovascular diseases
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Government Initiatives aimed at improving healthcare outcomes
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High costs
    • 3.2.2.2. Regulatory challenge
• 3.3. Cardiac Safety Services Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Cardiac Safety Services Market: Service Estimates & Trend Analysis

• 4.1. Global Cardiac Safety Services Market: Service Dashboard
• 4.2. Global Cardiac Safety Services Market: Service Movement Analysis
• 4.3. Global Cardiac Safety Services Market by Service, Revenue
• 4.4. ECG/ Holter Monitors
  • 4.4.1. ECG/ Holter Monitors market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.1. ECG Patch
      • 4.4.1.1.1. ECG Patch market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.2. Holter Monitors
    • 4.4.1.3. Holter Monitors market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Blood Pressure Monitors
  • 4.5.1. Blood Pressure Monitors market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.1.1. Aneroid Blood Pressure Monitors
      • 4.5.1.1.1. Aneroid Blood Pressure Monitors market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.1.2. Digital Blood Pressure Monitors
      • 4.5.1.2.1. Digital Blood Pressure Monitors market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.1.3. Ambulatory Blood Pressure Monitors
      • 4.5.1.3.1. Ambulatory Blood Pressure Monitors market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Cardiovascular Imaging
  • 4.6.1. Cardiovascular Imaging market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.1.1. CT
      • 4.6.1.1.1. CT market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.1.2. MRI
      • 4.6.1.2.1. MRI market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.1.3. Ultrasound
      • 4.6.1.3.1. Ultrasound market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.1.4. Nuclear Medicine
      • 4.6.1.4.1. Nuclear Medicine market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Others
  • 4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Cardiac Safety Services Market: Type Estimates & Trend Analysis

• 5.1. Global Cardiac Safety Services Market: Type Dashboard
• 5.2. Global Cardiac Safety Services Market: Type Movement Analysis
• 5.3. Global Cardiac Safety Services Market Estimates and Forecasts, By Type, Revenue (USD Million)
• 5.4. Integrated
  • 5.4.1. Integrated market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Standalone
  • 5.5.1. Standalone market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Cardiac Safety Services Market: End Use Estimates & Trend Analysis

• 6.1. Global Cardiac Safety Services Market: End Use Dashboard
• 6.2. Global Cardiac Safety Services Market: End Use Movement Analysis
• 6.3. Global Cardiac Safety Services Market Estimates and Forecasts, By End Use, Revenue (USD Million)
• 6.4. Pharma & Biopharma Companies
  • 6.4.1. Pharma & Biopharma Companies market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. CROs
  • 6.5.1. CROs market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Other
  • 6.6.1. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Cardiac Safety Services Market: Regional Estimates & Trend Analysis by Treatment, Type, and End Use

• 7.1. Regional Dashboard
• 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework/ reimbursement structure
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.3. Mexico
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.6. Norway
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
• 8.2. Vendor Landscape
  • 8.2.1. List of key distributors and channel partners
  • 8.2.2. Key company market share analysis, 2023
  • 8.2.3. Medpace
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Service benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. IQVIA
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Service benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. PPD Inc.
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Service benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Charles River Laboratories
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Service benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Wuxi AppTec
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Service benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Eurofins Scientific
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Service benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Celerion
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Service benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Nova Research Laboratories
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Service benchmarking
    • 8.2.10.4. Strategic initiatives
  • 8.2.11. Laboratory Corporation of America Holdings
    • 8.2.11.1. Company overview
    • 8.2.11.2. Financial performance
    • 8.2.11.3. Service benchmarking
    • 8.2.11.4. Strategic initiatives
  • 8.2.12. Koninklije Philips N.V.
    • 8.2.12.1. Company overview
    • 8.2.12.2. Financial performance
    • 8.2.12.3. Service benchmarking
    • 8.2.12.4. Strategic initiatives
  • 8.2.13. ICON Plc.
    • 8.2.13.1. Company overview
    • 8.2.13.2. Financial performance
    • 8.2.13.3. Service benchmarking
    • 8.2.13.4. Strategic initiatives
  • 8.2.14. SGS S.A.
    • 8.2.14.1. Company overview
    • 8.2.14.2. Financial performance
    • 8.2.14.3. Service benchmarking
    • 8.2.14.4. Strategic initiatives
  • 8.2.15. Clario
    • 8.2.15.1. Company overview
    • 8.2.15.2. Financial performance
    • 8.2.15.3. Service benchmarking
    • 8.2.15.4. Strategic initiatives
  • 8.2.16. Certara
    • 8.2.16.1. Company overview
    • 8.2.16.2. Financial performance
    • 8.2.16.3. Service benchmarking
    • 8.2.16.4. Strategic initiatives